| 1977-11 |
November 1977: Founded as a clinical reagent sales company in Hakata-ku, Fukuoka City (capital 5 million yen). |
| 1977-11 |
Established as a clinical reagent sales company in Hakata-ku, Fukuoka City (capital of 5 million yen). |
| 1981-09 |
September 1981: Moved headquarters to Tosu City, Saga Prefecture (new corporate building completed) and changed business purpose to an in vitro diagnostic pharmaceutical manufacturing and sales company. |
| 1981-09 |
Relocated headquarters to Tosu City, Saga Prefecture (new headquarters completed): changed business purpose to an in vitro diagnostic drug manufacturing and sales company. |
| 1983-03 |
March 1983: Company name changed to Mizuhome Media Co., Ltd. |
| 1983-03 |
Company name changed to Mizho Medical Co., Ltd. |
| 1983-08 |
August 1983: Established Tokyo branch office. |
| 1983-08 |
Opened Tokyo branch office. |
| 1983-10 |
October 1983: Established Osaka branch office. |
| 1983-10 |
Opened Osaka branch office. |
| 1984-05 |
May 1984: Started overseas exports. |
| 1984-05 |
Commenced overseas exports. |
| 1986-07 |
July 1986: Established Nagoya branch office. |
| 1986-07 |
Opened Nagoya branch office. |
| 1988-12 |
December 1988: Capital increased to 95 million yen. |
| 1988-12 |
Capital increased to 95 million yen. |
| 1989-09 |
September 1989: Moved headquarters (new factory completed in Tosu City, Saga Prefecture). |
| 1989-09 |
Relocated headquarters (new factory completed in Tosu City, Saga Prefecture). |
| 1990-12 |
December 1990: Capital increased to 3.2975 billion yen. |
| 1990-12 |
Capital increased to 329.75 million yen. |
| 1995-03 |
March 1995: Expanded headquarters factory (Tosu City, Saga Prefecture). |
| 1995-03 |
Expanded headquarters factory (Tosu City, Saga Prefecture). |
| 1997-10 |
October 1997: Established OTC division (for pharmacies and drugstores). |
| 1997-10 |
Established OTC division (for pharmacies and drugstores). |
| 2004-10 |
October 2004: Started selling products to practicing physicians (influenza test kits). |
| 2004-10 |
Commenced sales of products for general practitioners (influenza test kits). |
| 2005-03 |
March 2005: Expanded headquarters warehouse (Tosu City, Saga Prefecture). |
| 2005-03 |
Expanded headquarters warehouse (Tosu City, Saga Prefecture). |
| 2008-09 |
September 2008: Obtained ISO 13485 certification. |
| 2008-09 |
Obtained ISO 13485 certification. |
| 2010-09 |
September 2010: Expanded headquarters factory (Tosu City, Saga Prefecture). |
| 2010-09 |
Expanded headquarters factory (Tosu City, Saga Prefecture). |
| 2012-09 |
September 2012: Expanded headquarters testing and research building (Tosu City, Saga Prefecture). |
| 2012-09 |
Expanded headquarters research and testing building (Tosu City, Saga Prefecture). |
| 2015-12 |
December 2015: Listed on the JASDAQ market of the Tokyo Stock Exchange: capital increased to 464.54 million yen (current). |
| 2015-12 |
Listed on the Tokyo Stock Exchange JASDAQ market: increased capital to 464.54 million yen (current). |
| 2018-02 |
February 2018: Obtained domestic manufacturing and sales approval for the respiratory infection gene test kit (Smart Gene Myco). |
| 2018-02 |
Obtained domestic manufacturing and sales approval for the respiratory infection gene test kit (Smart Gene Myco). |
| 2018-10 |
October 2018: Commenced sales of the fully automated gene analysis device (Smart Gene) and the respiratory infection gene test kit (Smart Gene Myco). |
| 2018-10 |
Commenced sales of the fully automated gene analysis device (Smart Gene) and the respiratory infection gene test kit (Smart Gene Myco). |
| 2018-11 |
November 2018: Moved to the Second Section of the Tokyo Stock Exchange. |
| 2018-11 |
Moved to the Second Section of the Tokyo Stock Exchange market. |
| 2019-05 |
May 2019: Completion of the Kurume factory and gene research institute (Kurume City, Fukuoka Prefecture). |
| 2019-05 |
Completed Kurume factory and gene research institute (Kurume City, Fukuoka Prefecture). |
| 2019-09 |
September 2019: Commencement of operations at the Kurume factory and gene research institute (Kurume City, Fukuoka Prefecture). |
| 2019-09 |
Commenced operation of Kurume factory and gene research institute (Kurume City, Fukuoka Prefecture). |
| 2020-08 |
August 2020: Began sales of the COVID-19 gene test kit (Smart Gene COVID-19 Detection Reagent) as a research reagent under public medical insurance coverage. |
| 2020-08 |
Commenced sales of the COVID-19 gene test kit (Smart Gene COVID-19 Detection Reagent) as a research reagent under public medical insurance coverage. |
| 2021-04 |
April 2021: Commenced sales of Smart Gene SARS-CoV-2, a legally approved in vitro diagnostic drug, replacing the research reagent (Smart Gene COVID-19 Detection Reagent) under public medical insurance coverage. |
| 2021-04 |
Commenced sales of the in vitro diagnostic drug (Smart Gene SARS-CoV-2) approved as a replacement for the research reagent (Smart Gene COVID-19 Detection Reagent) under public medical insurance coverage. |
| 2022-04 |
April 2022: Transitioned from the Second Section to the new Standard Market following the Tokyo Stock Exchange market reclassification. |
| 2022-04 |
Transitioned from the Second Section to the new 'Standard Market' division following the Tokyo Stock Exchange market reorganization. |
